408 related articles for article (PubMed ID: 8182763)
1. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.
Altman DG; Lausen B; Sauerbrei W; Schumacher M
J Natl Cancer Inst; 1994 Jun; 86(11):829-35. PubMed ID: 8182763
[No Abstract] [Full Text] [Related]
2. Re: Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.
Cantor AB; Shuster JJ
J Natl Cancer Inst; 1994 Dec; 86(23):1798-9. PubMed ID: 7966421
[No Abstract] [Full Text] [Related]
3. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
Lipponen P; Papinaho S; Eskelinen M; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
Anticancer Res; 1992; 12(5):1533-8. PubMed ID: 1444217
[TBL] [Abstract][Full Text] [Related]
4. [DNA ploidy pattern, S-phase fraction as a prognostic factor of breast cancers].
Kimijima I; Katagata N; Tsuchiya A; Takenoshita S
Nihon Rinsho; 2000 Apr; 58 Suppl():401-6. PubMed ID: 11026024
[No Abstract] [Full Text] [Related]
5. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
6. Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example.
Winzer KJ; Buchholz A; Schumacher M; Sauerbrei W
PLoS One; 2016; 11(3):e0149977. PubMed ID: 26938061
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
[TBL] [Abstract][Full Text] [Related]
8. Ki-67, p53, ER receptors, ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancer.
Railo M; Lundin J; Haglund C; von Smitten K; Nordling S
Tumour Biol; 2007; 28(1):45-51. PubMed ID: 17143016
[TBL] [Abstract][Full Text] [Related]
9. Prognostic indexes in breast cancer: comparison of the Nottingham and Adelaide indexes.
Sidoni A; Bellezza G; Cavaliere A; Del Sordo R; Scheibel M; Bucciarelli E
Breast; 2004 Feb; 13(1):23-7. PubMed ID: 14759712
[TBL] [Abstract][Full Text] [Related]
10. Comment on the Nottingham Prognostic Index.
Brown J; Jones M; Benson EA
Breast Cancer Res Treat; 1993; 25(3):283. PubMed ID: 8267734
[No Abstract] [Full Text] [Related]
11. Breast cancer prognostication in the 21st century and the Nottingham prognostic index.
Anderson TJ
J Clin Pathol; 2002 Feb; 55(2):86-7. PubMed ID: 11864999
[No Abstract] [Full Text] [Related]
12. Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma.
Pinto AE; André S; Pereira T; Nóbrega S; Soares J
J Clin Pathol; 2001 Jul; 54(7):543-9. PubMed ID: 11429427
[TBL] [Abstract][Full Text] [Related]
13. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
Isola J; Visakorpi T; Holli K; Kallioniemi OP
J Natl Cancer Inst; 1992 Jul; 84(14):1109-14. PubMed ID: 1352359
[TBL] [Abstract][Full Text] [Related]
14. S-phase fraction is a prognostic factor in stage I breast carcinoma.
Stål O; Dufmats M; Hatschek T; Carstensen J; Klintenberg C; Rutqvist LE; Skoog L; Sullivan S; Wingren S; Nordenskjöld B
J Clin Oncol; 1993 Sep; 11(9):1717-22. PubMed ID: 8355038
[TBL] [Abstract][Full Text] [Related]
15. On the clinical significance of the S-phase fractions of tumors.
Johnson HA
Ann Clin Lab Sci; 1994; 24(5):431-5. PubMed ID: 7818238
[TBL] [Abstract][Full Text] [Related]
16. Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 cases.
Caly M; Genin P; Ghuzlan A A; Elie C; Fréneaux P; Klijanienko J; Rosty C; Sigal-Zafrani B; Vincent-Salomon A; Douggaz A; Zidane M; Sastre-Garau X
Anticancer Res; 2004; 24(5B):3283-8. PubMed ID: 15510624
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.
Jalava P; Kuopio T; Huovinen R; Laine J; Collan Y
Anticancer Res; 2005; 25(3c):2535-42. PubMed ID: 16080489
[TBL] [Abstract][Full Text] [Related]
18. Proliferative activity in primary breast carcinomas is a salient prognostic factor.
Michels JJ; Marnay J; Delozier T; Denoux Y; Chasle J
Cancer; 2004 Feb; 100(3):455-64. PubMed ID: 14745860
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
20. Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet?
Schnitt SJ; Harris JR; Smith BL
Cancer; 1996 Jun; 77(11):2189-92. PubMed ID: 8635082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
